Riskpilot← Back to searchSign inGet full accessSAGENE ALLMENNKLINIKK AS
ASActiveOrg 925503622Bergensgata 12, 0468 OsloGeneral medical practice activities · NACE 8621Est. 20205 employees
Revenue 2024
NOK 1,5M
-4% vs 2023
EBITDA margin
1.9%
+1129% vs 2023
Equity ratio
-1.4%
Financial strength
Net profit 2024
NOK 18K
+401% vs 2023
| Revenue | NOK 1,5M | -4% |
| EBITDA | NOK 28K | +1129% |
| Net profit | NOK 18K | +401% |
| Total assets | NOK 170K | +28% |
| Equity | NOK -2K | +88% |
| Employees | 5 | — |
Legal name
SAGENE ALLMENNKLINIKK AS
Org number
925503622
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. august 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Være et driftsselskap som skal tilrettelegge og drifte fellesfunksjonene for de legevirksomhetene som utføres i selskapet.
Address
Bergensgata 12, 0468 Oslo
Phone
+4722026100
Email
post@akerselvamedisinskesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 632 | 2 369 | 2 484 | 1 539 | 1 472 |
| Staff expenses | −412 | −1 176 | −1 050 | −767 | −693 |
| EBITDA | −29 | −98 | 114 | 2 | 28 |
| Depreciation & amort. | −0 | −0 | −8 | −6 | −5 |
| EBIT | −29 | −98 | 106 | −4 | 23 |
| Net financials | 0 | −1 | −1 | −0 | −0 |
| Profit before tax | −29 | −99 | 105 | −4 | 23 |
| Tax | −9 | −5 | 25 | 2 | 5 |
| Net profit | −20 | −93 | 80 | −6 | 18 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 257 | 156 | 205 | 133 | 170 |
| Equity | −1 | −94 | −15 | −21 | −2 |
| Long-term debt | 0 | 0 | 0 | 0 | 4 |
| Short-term debt | 258 | 250 | 219 | 154 | 168 |
| Total debt | 258 | 250 | 219 | 154 | 172 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20202024
Equity ratio
-1.4%
This company
38.2%
Market median
-104% vs market
20202024
Return on equity
1821400.0%
This company
18.4%
Market median
+9898813% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
8.67×
This company
1.12×
Market median
+674% vs market
20202024
Debt / equity
72.46×
This company
0.62×
Market median
-11587% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (1) | ||
RC Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Chairman | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAGENE ALLMENNKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rosemary Chinyereugo Onyii Oche | Chief Executive Officer | 0 companies |
| Tehua Michael Xu | Chief Executive Officer | 0 companies |
| Rosemary Oche Kwengoua | Chairman | 0 companies |
| Nusrat Hussain | Chairman | 0 companies |